Active collagen vascular disease, specifically dermatomyositis with a creatinine phosphokinase (CPK) level above normal or with an active skin rash, systemic lupus erythematosus, or scleroderma
Active collagen vascular disease, specifically dermatomyositis with a creatine phosphokinase (CPK) level above normal or with an active skin rash, systemic lupus erythematosus, or scleroderma
Dermatomyositis with a creatine phosphokinase (CPK) level above normal or with an active skin rash or scleroderma
Collagen vascular disease, specifically dermatomyositis with a CPK level above normal or with an active skin rash, systemic lupus erythematosis, or scleroderma.
Active collagen vascular diseases, such as: systemic lupus erythematous, scleroderma, or dermatomyositis
Patients with active collagen vascular disease (CVD), specifically systemic lupus erythematosus or scleroderma; patients with a history of CVD without evidence of active disease are eligible for enrollment at the discretion of the study PI
Active systemic lupus, erythematosus, or any history of scleroderma, dermatomyositis with active rash
Patients with collagen vascular disease, specifically dermatomyositis with a creatine phosphokinase (CPK) level above normal or active skin rash, systemic lupus erythematosus, or scleroderma
Collagen vascular disease, specifically dermatomyositis with a creatine phosphokinase (CPK) level above normal or with an active skin rash, systemic lupus erythematosus, or scleroderma
Significant infection or other co-existing medical condition that would preclude protocol therapy such as pregnancy, HIV/AIDS or collagen vascular diseases specifically systemic lupus erythematosus, scleroderma, or dermatomyositis.
Documented diagnosis of collagen vascular disease, specifically dermatomyositis with a creatinine phosphokinase (CPK) level above normal or with an active skin rash, systemic lupus erythematosus, or scleroderma
Patients with collagen vascular diseases, specifically systemic lupus erythematosus, scleroderma, or dermatomyositis
Diagnosis of active dermatomyositis
Diagnosis of systemic lupus erythematosus, scleroderma, or dermatomyositis
Patient must not have active systemic lupus erythematosus, or any history of active scleroderma, or dermatomyositis with active rash
Active systemic lupus erythematosus, or any history of active scleroderma, dermatomyositis with active rash
Patients with active inflammatory bowel disease or collagen vascular disease systemic lupus erythematosus (SLE), scleroderma
Patients with collagen vascular disease, specifically dermatomyositis with a creatine phosphokinase (CPK) level above normal or active skin rash, systemic lupus erythematosus, or scleroderma
Patients with history of collagen vascular disease, specifically dermatomyositis with a creatine phosphokinase (CPK) level above normal or active skin rash, systemic lupus erythematosus, or scleroderma
Patients who have contraindications to radiotherapy, such as scleroderma, dermatomyositis, or severe cutaneous manifestations of systemic lupus erythematosus (SLE)
No active collagen vascular diseases, such as: systemic lupus erythematous, scleroderma, or dermatomyositis
Active collagen vascular disease, specifically dermatomyositis with a creatine kinase (CPK) level above normal or with an active skin rash, systemic lupus erythematosus, or scleroderma